CDKN2BAS1/ANRIL, located in the 9p21 chromosomic region, has been reported in numerous studies as a genetic risk locus for CAD, intracranial aneurysms and diverse cardiometabolic disorders (32). Here, CDKN2B-AS1 is linked to coronary artery disorder.